Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
Department of Human Structure and Repair, Faculty of Medicine, Ghent University, Ghent, Belgium.
Ann Surg Oncol. 2020 Jul;27(7):2370-2380. doi: 10.1245/s10434-020-08243-w. Epub 2020 Feb 14.
Laparoscopic ablation (LA) of colorectal liver metastases (CRLMs) is frequently performed in combination with laparoscopic liver resection or as a stand-alone procedure. However, LA is technically demanding and whether the results are comparable with those of open ablation (OA) has not been determined to date. This study compared the effectiveness of LA and OA in achieving local tumor control of CRLMs.
Patients undergoing LA or OA of CRLMs at Ghent University Hospital between June 2007 and February 2018 were identified from a prospective database. Lesions treated by LA and OA were matched 1:1 using a propensity score based on lesions (liver segment, size, deepness, proximity to a vessel), patients, and procedural characteristics. Ablation sites were followed up with computed-tomography or magnetic resonance imaging to assess the completeness of the ablation and ablation-site recurrence (ASR). Analysis of ASR was performed with the Kaplan-Meier method and Cox regression.
In this study, 163 patients underwent the surgical ablation (78 LA, 85 OA) of 333 CRLMs (143 LA, 190 OA). After matching, 220 lesions (110 LA, 110 OA) were analyzed. Ablation was complete in 93.7% (LA) and 97.3% (OA) of the sites (p = 0.195). No difference in ASR was observed (p = 0.351), with a cumulative risk of ASR at 12 months of 9.1% (LA) and 8.2% (OA). After multivariable analysis, ASR was confirmed to be independent of the surgical approach.
The findings showed that LA and OA achieve a comparable local control of CRLMs. This result further supports the adoption of a laparoscopic approach for the treatment of CRLMs.
腹腔镜消融(LA)联合腹腔镜肝切除术或作为独立手术广泛应用于结直肠癌肝转移(CRLMs)的治疗。然而,LA 技术要求较高,其疗效是否与开放消融(OA)相当尚未确定。本研究比较了 LA 和 OA 治疗 CRLMs 的局部肿瘤控制效果。
本研究从前瞻性数据库中筛选出 2007 年 6 月至 2018 年 2 月期间在根特大学医院接受 LA 或 OA 治疗的 CRLMs 患者。采用基于病变(肝段、大小、深度、毗邻血管)、患者和手术特征的倾向评分匹配 LA 和 OA 治疗的病变,每组 1:1。采用计算机断层扫描或磁共振成像对消融部位进行随访,以评估消融的完整性和消融部位复发(ASR)。采用 Kaplan-Meier 法和 Cox 回归分析 ASR。
本研究中,163 例患者接受了 333 个 CRLMs(143 个 LA,190 个 OA)的手术消融(78 个 LA,85 个 OA)。匹配后,共分析了 220 个病灶(110 个 LA,110 个 OA)。93.7%(LA)和 97.3%(OA)的消融部位完全消融(p=0.195)。ASR 无显著差异(p=0.351),12 个月时的累积 ASR 风险分别为 9.1%(LA)和 8.2%(OA)。多变量分析证实,ASR 独立于手术方法。
本研究结果表明,LA 和 OA 治疗 CRLMs 的局部控制效果相当。这一结果进一步支持了腹腔镜治疗 CRLMs 的应用。